The cardiovascular software developer has built modelling programs that could help doctors decide whether patients are fit for surgery.
Feops, a Belgium-based cardiovascular modelling software spinout from Ghent University, has obtained €6m ($7.1m) in series B funding from a consortium including Flemish government-owned investment firm Participatiemaatschappij Vlaanderen (PMV).
The round was led by private equity firm Valiance Asset Management and also featured venture capital firm Capricorn Venture Partners.
Feops offers 3D cardiovascular modelling that can provide detailed imaging of patients awaiting heart surgery.
The company’s first product, TaviGuide, has already been commercialised, while a suite currently under development, Feops…
